Searchable abstracts of presentations at key conferences in endocrinology

ea0070yi11 | Young Investigators | ECE2020

Growth hormone-releasing hormone (GHRH) antagonists increase the sensitivity to radiotherapy in lung cancer cells

Gesmundo Iacopo , Dematteis Alessandro , Fanciulli Alessandro , Romana Giglioli Francesca , Cai Renzhi , Sha Wei , Ricardi Umberto , Ghigo Ezio , Schally Andrew V , Granata Riccarda

Growth hormone-releasing hormone (GHRH), apart from stimulating GH secretion in the pituitary, exerts many extrapituitary functions, including stimulation of cell proliferation and survival. GHRH and its receptor splice variants (SVs) are expressed in different cancer cell types, where they modulate cell growth. It has been shown that GHRH antagonists exert anticancer activities in a variety of tumors, including malignant pleural mesothelioma and lung cancer, one of the leadin...

ea0099p396 | Late-Breaking | ECE2024

Growth hormone-releasing hormone (GHRH) antagonists enhance radiosensitivity in non-small cell lung cancer cells

Gesmundo Iacopo , Pedrolli Francesca , Romana Giglioli Francesca , Bertoldo Alessia , Gregorc Vanesa , Sapino Anna , Righi Luisella , Cai Renzhi , Sha Wei , Giulio Papotti Mauro , Ghigo Ezio , V. Schally Andrew , Ricardi Umberto , Granata Riccarda

Growth hormone-releasing hormone (GHRH), apart from stimulating GH secretion in the pituitary, exerts many peripheral functions, including stimulation of cell proliferation and survival. In fact, GHRH and GHRH receptors (GHRH-Rs) are expressed in different cancer cell types, where they promote proliferation and survival. Conversely, GHRH antagonists exert antineoplastic activities in several tumors, including lung cancer, one of the leading causes of death by cancer worldwide....